Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of imatinib for plexiform neurofibromas in neurofibromatosis type 1
2012-000869-21Phase 2Active
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in plexiform neurofibroma (PN) and neurofibromatosis type 1 (NF1), sponsored by Carlo Besta Neurological Institute. Primary endpoints: Proportion of patients with stable tumor volume and Progression-free survival. Started Mar 2012; status: active.
02
Drugs
03
Conditions
plexiform neurofibroma (PN)neurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on 2012-000869-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000869-21.